Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Fellström BC[au]:

Search results

Items: 25

1.

Exome-Based Rare-Variant Analyses in CKD.

Cameron-Christie S, Wolock CJ, Groopman E, Petrovski S, Kamalakaran S, Povysil G, Vitsios D, Zhang M, Fleckner J, March RE, Gelfman S, Marasa M, Li Y, Sanna-Cherchi S, Kiryluk K, Allen AS, Fellström BC, Haefliger C, Platt A, Goldstein DB, Gharavi AG.

J Am Soc Nephrol. 2019 Jun;30(6):1109-1122. doi: 10.1681/ASN.2018090909. Epub 2019 May 13.

PMID:
31085678
2.

Diagnostic Utility of Exome Sequencing for Kidney Disease.

Groopman EE, Marasa M, Cameron-Christie S, Petrovski S, Aggarwal VS, Milo-Rasouly H, Li Y, Zhang J, Nestor J, Krithivasan P, Lam WY, Mitrotti A, Piva S, Kil BH, Chatterjee D, Reingold R, Bradbury D, DiVecchia M, Snyder H, Mu X, Mehl K, Balderes O, Fasel DA, Weng C, Radhakrishnan J, Canetta P, Appel GB, Bomback AS, Ahn W, Uy NS, Alam S, Cohen DJ, Crew RJ, Dube GK, Rao MK, Kamalakaran S, Copeland B, Ren Z, Bridgers J, Malone CD, Mebane CM, Dagaonkar N, Fellström BC, Haefliger C, Mohan S, Sanna-Cherchi S, Kiryluk K, Fleckner J, March R, Platt A, Goldstein DB, Gharavi AG.

N Engl J Med. 2019 Jan 10;380(2):142-151. doi: 10.1056/NEJMoa1806891. Epub 2018 Dec 26.

PMID:
30586318
3.

Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial.

Fellström BC, Barratt J, Cook H, Coppo R, Feehally J, de Fijter JW, Floege J, Hetzel G, Jardine AG, Locatelli F, Maes BD, Mercer A, Ortiz F, Praga M, Sørensen SS, Tesar V, Del Vecchio L; NEFIGAN Trial Investigators.

Lancet. 2017 May 27;389(10084):2117-2127. doi: 10.1016/S0140-6736(17)30550-0. Epub 2017 Mar 28.

PMID:
28363480
4.

Model comparisons of competing risk and recurrent events for graft failure in renal transplant recipients.

Holme I, Fellström BC, Jardine AG, Hartmann A, Holdaas H.

Clin J Am Soc Nephrol. 2013 Feb;8(2):241-7. doi: 10.2215/CJN.03760412. Epub 2012 Nov 15.

5.

Prevention of cardiovascular disease in adult recipients of kidney transplants.

Jardine AG, Gaston RS, Fellstrom BC, Holdaas H.

Lancet. 2011 Oct 15;378(9800):1419-27. doi: 10.1016/S0140-6736(11)61334-2. Review.

PMID:
22000138
6.

Prognostic model for total mortality in patients with haemodialysis from the Assessments of Survival and Cardiovascular Events (AURORA) study.

Holme I, Fellström BC, Jardin AG, Schmieder RE, Zannad F, Holdaas H.

J Intern Med. 2012 May;271(5):463-71. doi: 10.1111/j.1365-2796.2011.02435.x. Epub 2011 Sep 2.

7.

Rosuvastatin in diabetic hemodialysis patients.

Holdaas H, Holme I, Schmieder RE, Jardine AG, Zannad F, Norby GE, Fellström BC; AURORA study group.

J Am Soc Nephrol. 2011 Jul;22(7):1335-41. doi: 10.1681/ASN.2010090987. Epub 2011 May 12.

8.

Cardioprotective role of statins in chronic kidney disease: do we have the answer?

Fellström BC.

Kidney Int. 2011 May;79(9):931-2. doi: 10.1038/ki.2011.6.

9.

Cardiovascular disease in renal transplant recipients.

McQuarrie EP, Fellström BC, Holdaas H, Jardine AG.

J Ren Care. 2010 May;36 Suppl 1:136-45. doi: 10.1111/j.1755-6686.2010.00160.x. Review.

PMID:
20586909
10.

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.

Fellström BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Grönhagen-Riska C, De Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Süleymanlar G, Tsakiris D, Tesar V, Todorov V, Wiecek A, Wüthrich RP, Gottlow M, Johnsson E, Zannad F; AURORA Study Group.

N Engl J Med. 2009 Apr 2;360(14):1395-407. doi: 10.1056/NEJMoa0810177. Epub 2009 Mar 30. Erratum in: N Engl J Med. 2010 Apr 15;362(15):1450.

11.

Ischemia-induced renal expression of hyaluronan and CD44 in diabetic rats.

Melin J, Hellberg O, Funa K, Hällgren R, Larsson E, Fellström BC.

Nephron Exp Nephrol. 2006;103(3):e86-94. Epub 2006 Mar 22.

PMID:
16554665
12.

Why do we need a statin trial in hemodialysis patients?

Fellström BC, Holdaas H, Jardine AG.

Kidney Int Suppl. 2003 May;(84):S204-6. Review.

PMID:
12694345
13.

Protective effect of insulin on ischemic renal injury in diabetes mellitus.

Melin J, Hellberg O, Larsson E, Zezina L, Fellström BC.

Kidney Int. 2002 Apr;61(4):1383-92.

14.

Tolerance induction ameliorates allograft vasculopathy in rat aortic transplants. Influence of Fas-mediated apoptosis.

Akyürek LM, Johnsson C, Lange D, Georgii-Hemming P, Larsson E, Fellström BC, Funa K, Tufveson G.

J Clin Invest. 1998 Jun 15;101(12):2889-99.

15.

Ischemia causes rapidly progressive nephropathy in the diabetic rat.

Melin J, Hellberg O, Akyürek LM, Källskog O, Larsson E, Fellström BC.

Kidney Int. 1997 Oct;52(4):985-91.

16.

Nitric oxide generation by nitric oxide synthase isoforms in transplanted vessels.

Akyürek ML, Hansson GK, Larsson E, Fellström BC.

Transplant Proc. 1997 Sep;29(6):2571-2. Review. No abstract available.

PMID:
9290745
17.

Inducible and endothelial nitric oxide synthase expression during development of transplant arteriosclerosis in rat aortic grafts.

Akyürek LM, Fellström BC, Yan ZQ, Hansson GK, Funa K, Larsson E.

Am J Pathol. 1996 Dec;149(6):1981-90.

18.

Smooth muscle cell migration into intima and adventitia during development of transplant vasculopathy.

Akyürek LM, Paul LC, Funa K, Larsson E, Fellström BC.

Transplantation. 1996 Nov 27;62(10):1526-9.

PMID:
8958288
19.

Nonimmunologic factors involved in long-term renal allograft deterioration.

Fellström BC, Akyürek ML, Dimény EM, Kaijser M, Larsson E, Wanders A, Wahlberg J.

Adv Nephrol Necker Hosp. 1996;25:51-62. Review. No abstract available.

PMID:
8717620
20.

Experimental transplant arteriosclerosis: inhibition by angiopeptin and low molecular weight heparin derivatives.

Akyürek ML, Larsson E, Funa K, Wanders A, Kaijser M, Fellström BC.

Transplant Proc. 1995 Dec;27(6):3555-6. No abstract available.

PMID:
8540099
21.

Inhibition of transplant arteriosclerosis in rat aortic grafts by low molecular weight heparin derivatives.

Akyürek LM, Funa K, Wanders A, Larsson E, Fellström BC.

Transplantation. 1995 Jun 15;59(11):1517-24.

PMID:
7778166
22.

Expression of CD11b and ICAM-1 in an in vivo model of transplant arteriosclerosis.

Akyürek ML, Funa K, Wanders A, Larsson E, Fellström BC.

Transpl Immunol. 1995 Jun;3(2):107-13.

PMID:
7582901
23.

Effects of angiopeptin on transplant arteriosclerosis in the rat.

Akyürek ML, Wanders A, Aurivillius M, Larsson E, Funa K, Fellström BC.

Transpl Int. 1995;8(2):103-10.

PMID:
7766291
24.

Presence of polymorphonuclear granulocytes during the early stage of transplant arteriosclerosis after prolonged ischemia in the rat.

Wanders A, Akyürek ML, Larsson E, Fellström BC.

Transpl Int. 1994;7 Suppl 1:S371-5.

PMID:
11271255
25.

Pathogenesis and treatment perspectives of chronic graft rejection (CVR).

Fellström BC, Larsson E.

Immunol Rev. 1993 Aug;134:83-98. Review.

PMID:
8225376

Supplemental Content

Loading ...
Support Center